A radiomic signature correlated with immune-related lncRNA expression and infiltration by CD8+ T cells, M2 macrophages, and resting memory CD4+ T cells, alongside immune checkpoint expression (PD-L1, CTLA-4), highlighting its potential for immunotherapy stratification in GBM (76). The gene discussed is CTLA4; the disease is glioblastoma.